Termination of persistent atrial fibrillation during pulmonary vein isolation: insight from the MAGIC-AF trial

Aims Controversy on the optimal ablation strategy for persistent atrial fibrillation (AF) exists with limited work evaluating a strategy of pulmonary vein isolation (PVI) alone when AF terminates during PVI. Thirty-five patients had AF termination during PVI in the Modified Ablation Guided by Ibutilide Use in Chronic Atrial Fibrillation (MAGIC-AF; ClinicalTrials.gov number: NCT01014741) study. The objective of the current study is to report the 1-year outcome after PVI alone in this unique patient group. Methods and results The 1-year single procedure freedom from atrial arrhythmia off anti-arrhythmic drugs was reported for the 35 patients in the MAGIC-AF study with persistent AF termination during or upon completion of PVI. Freedom from recurrent atrial arrhythmia was achieved in 60% of patients where AF terminated during PVI. Cavotricuspid isthmus flutter was common when AF terminated to a macro re-entrant flutter during PVI, and responsible for 92% of all flutter circuits with AF termination. Conclusions Persistent AF termination during PVI may identify a subgroup of patients who experience a similar long-term clinical outcome with PVI ablation alone when compared with other more extensive persistent AF ablation strategies. Pulmonary vein isolation alone may be an appropriate tactic in this subgroup of persistent AF patients.

[1]  E. Heist,et al.  The modified stepwise ablation guided by low-dose ibutilide in chronic atrial fibrillation trial (The MAGIC-AF Study). , 2016, European heart journal.

[2]  S. Willems,et al.  Pulmonary Vein Isolation Versus Defragmentation: The CHASE-AF Clinical Trial. , 2015, Journal of the American College of Cardiology.

[3]  G. Hindricks,et al.  Prospective, multicenter validation of a clinical risk score for left atrial arrhythmogenic substrate based on voltage analysis: DR-FLASH score. , 2015, Heart rhythm.

[4]  Young-Hoon Kim,et al.  Atrial fibrillation cycle length as a predictor for the extent of substrate ablation. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[5]  A. Verma,et al.  Catheter Ablation for Persistent Atrial Fibrillation. , 2015, The New England journal of medicine.

[6]  Prashanthan Sanders,et al.  Approaches to catheter ablation for persistent atrial fibrillation. , 2015, The New England journal of medicine.

[7]  Hubert Cochet,et al.  Five-Year Outcome of Catheter Ablation of Persistent Atrial Fibrillation Using Termination of Atrial Fibrillation as a Procedural Endpoint , 2015, Circulation. Arrhythmia and electrophysiology.

[8]  Lluís Mont,et al.  Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study) , 2013, European heart journal.

[9]  Steven E. Williams,et al.  Persistent atrial fibrillation presenting in sinus rhythm: pulmonary vein isolation versus pulmonary vein isolation plus electrogram-guided ablation. , 2013, Archives of cardiovascular diseases.

[10]  M. Allessie,et al.  Bachmann’s Bundle: A Key Player in the Development of Atrial Fibrillation? , 2013, Circulation. Arrhythmia and electrophysiology.

[11]  B. Haller,et al.  Importance of Sinus Rhythm as Endpoint of Persistent Atrial Fibrillation Ablation , 2013, Journal of cardiovascular electrophysiology.

[12]  P. Jaïs,et al.  Catheter Ablation for Persistent Atrial Fibrillation: Elimination of Triggers Is Not Sufficient , 2012, Circulation. Arrhythmia and electrophysiology.

[13]  K. Kuck,et al.  Catheter ablation of long-standing persistent atrial fibrillation: 5-year outcomes of the Hamburg Sequential Ablation Strategy. , 2012, Journal of the American College of Cardiology.

[14]  David Keane,et al.  2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[15]  S. Mittal,et al.  Pulmonary Vein Isolation Alone in Patients with Persistent Atrial Fibrillation: An Ablation Strategy Facilitated by Antiarrhythmic Drug Induced Reverse Remodeling , 2010, Journal of cardiovascular electrophysiology.

[16]  Sanjay Dixit,et al.  Effect of pulmonary vein isolation on the distribution of complex fractionated electrograms in humans. , 2009, Heart rhythm.

[17]  A. Waldo,et al.  Fixed intercaval block in the setting of atrial fibrillation promotes the development of atrial flutter. , 2008, Heart rhythm.

[18]  Daniele Coin,et al.  Long-Term Clinical Results of 2 Different Ablation Strategies in Patients With Paroxysmal and Persistent Atrial Fibrillation , 2008, Circulation. Arrhythmia and electrophysiology.

[19]  Peng-Sheng Chen,et al.  Vein of Marshall Activity During Sustained Atrial Fibrillation , 2006, Journal of cardiovascular electrophysiology.

[20]  Yukiko Nakano,et al.  Impact of pulmonary vein isolation on fractionated atrial potentials and ganglionated plexi in patients with persistent atrial fibrillation. , 2014, International heart journal.

[21]  Wolters Kluwer,et al.  Hrs/ehra/ecas Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design: a Report of the Heart Rhythm Society (hrs) Task Force , 2022 .